{"title":"藤黄三萜及其与血管内皮生长因子受体-2的亲和力","authors":"Yupeng Zhai , Caixia Guo , Haojing Jiang , Hai-Jiang Zhang , Jing Xu , Yuanqiang Guo","doi":"10.1016/j.phytol.2025.102998","DOIUrl":null,"url":null,"abstract":"<div><div><em>Garcinia oligantha</em> Merr., a traditional herb, is widely used in folk medicines for the treatment of various ailments. To explore its potential medicinal value, a chemical investigation on <em>G. oligantha</em> was conducted, leading to the isolation and identification of five triterpenoids, including two new lupane-type triterpenes and three known oleanane-type triterpenes. The structures of these compounds were precisely elucidated using spectroscopic techniques, such as NMR, HRESIMS, and CD. To assess their potential bioactivity, affinity screening was performed, which revealed that compounds <strong>3</strong>−<strong>5</strong> exhibited significant affinity for vascular endothelial growth factor receptor 2 (VEGFR-2), an important target for anti-cancer drug development. Further molecular docking studies elucidated the binding modes of these compounds with VEGFR-2. This study not only enriches the understanding of the chemical constituents of <em>G. oligantha</em> but also provides potential bioactive molecules for the development of novel anti-cancer drugs.</div></div>","PeriodicalId":20408,"journal":{"name":"Phytochemistry Letters","volume":"68 ","pages":"Article 102998"},"PeriodicalIF":1.4000,"publicationDate":"2025-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Triterpenoids from Garcinia oligantha and their affinity with vascular endothelial growth factor receptor-2\",\"authors\":\"Yupeng Zhai , Caixia Guo , Haojing Jiang , Hai-Jiang Zhang , Jing Xu , Yuanqiang Guo\",\"doi\":\"10.1016/j.phytol.2025.102998\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div><em>Garcinia oligantha</em> Merr., a traditional herb, is widely used in folk medicines for the treatment of various ailments. To explore its potential medicinal value, a chemical investigation on <em>G. oligantha</em> was conducted, leading to the isolation and identification of five triterpenoids, including two new lupane-type triterpenes and three known oleanane-type triterpenes. The structures of these compounds were precisely elucidated using spectroscopic techniques, such as NMR, HRESIMS, and CD. To assess their potential bioactivity, affinity screening was performed, which revealed that compounds <strong>3</strong>−<strong>5</strong> exhibited significant affinity for vascular endothelial growth factor receptor 2 (VEGFR-2), an important target for anti-cancer drug development. Further molecular docking studies elucidated the binding modes of these compounds with VEGFR-2. This study not only enriches the understanding of the chemical constituents of <em>G. oligantha</em> but also provides potential bioactive molecules for the development of novel anti-cancer drugs.</div></div>\",\"PeriodicalId\":20408,\"journal\":{\"name\":\"Phytochemistry Letters\",\"volume\":\"68 \",\"pages\":\"Article 102998\"},\"PeriodicalIF\":1.4000,\"publicationDate\":\"2025-06-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Phytochemistry Letters\",\"FirstCategoryId\":\"99\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1874390025010882\",\"RegionNum\":4,\"RegionCategory\":\"生物学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"CHEMISTRY, MEDICINAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Phytochemistry Letters","FirstCategoryId":"99","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1874390025010882","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
Triterpenoids from Garcinia oligantha and their affinity with vascular endothelial growth factor receptor-2
Garcinia oligantha Merr., a traditional herb, is widely used in folk medicines for the treatment of various ailments. To explore its potential medicinal value, a chemical investigation on G. oligantha was conducted, leading to the isolation and identification of five triterpenoids, including two new lupane-type triterpenes and three known oleanane-type triterpenes. The structures of these compounds were precisely elucidated using spectroscopic techniques, such as NMR, HRESIMS, and CD. To assess their potential bioactivity, affinity screening was performed, which revealed that compounds 3−5 exhibited significant affinity for vascular endothelial growth factor receptor 2 (VEGFR-2), an important target for anti-cancer drug development. Further molecular docking studies elucidated the binding modes of these compounds with VEGFR-2. This study not only enriches the understanding of the chemical constituents of G. oligantha but also provides potential bioactive molecules for the development of novel anti-cancer drugs.
期刊介绍:
Phytochemistry Letters invites rapid communications on all aspects of natural product research including:
• Structural elucidation of natural products
• Analytical evaluation of herbal medicines
• Clinical efficacy, safety and pharmacovigilance of herbal medicines
• Natural product biosynthesis
• Natural product synthesis and chemical modification
• Natural product metabolism
• Chemical ecology
• Biotechnology
• Bioassay-guided isolation
• Pharmacognosy
• Pharmacology of natural products
• Metabolomics
• Ethnobotany and traditional usage
• Genetics of natural products
Manuscripts that detail the isolation of just one new compound are not substantial enough to be sent out of review and are out of scope. Furthermore, where pharmacology has been performed on one new compound to increase the amount of novel data, the pharmacology must be substantial and/or related to the medicinal use of the producing organism.